Relationship Between Native and Recombinant Cholecystokinin Receptors: Role of Differential Glycosylation

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Pancreas

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1097/00006676-199608000-00003PMID 8829180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides.

  2009cited by this paper
• CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).

  1995cited by this paper
• Dual pathways of internalization of the cholecystokinin receptor

  1995cited by this paper
• Characterization of the Substance P (NK‐1) Receptor in Tunicamycin‐Treated Transfected Cells Using a Photoaffinity Analogue of Substance P

  1995cited by this paper
• Conformational implications of asparagine-linked glycosylation.

  1995cited by this paper
• Heterotrimeric G proteins: organizers of transmembrane signals.

  1995cited by this paper
• Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle stimulating hormone in receptor binding and signal transduction.

  1994cited by this paper
• The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation.

  1994cited by this paper
• Structure and function in rhodopsin: the role of asparagine-linked glycosylation.

  1994cited by this paper
• Glycosylation of the GLP-1 receptor is a prerequisite for regular receptor function.

  1994cited by this paper
• Cloning by function: expression cloning in mammalian cells.

  1994cited by this paper
• How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum.

  1994cited by this paper
• Determination of plasma membrane lipid mass and composition in cultured Chinese hamster ovary cells using high gradient magnetic affinity chromatography.

  1993cited by this paper
• Dose-dependent recruitment of pancreatic acinar cells during receptor-mediated calcium mobilization.

  1993cited by this paper
• Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin.

  1993cited by this paper
• Receptor cloning and heterologous expression--towards a new tool for drug discovery.

  1993cited by this paper
• Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas.

  1992cited by this paper
• CircumVent thermal cycle sequencing and alternative manual and automated DNA sequencing protocols using the highly thermostable VentR (exo-) DNA polymerase.

  1992cited by this paper
• Expression cloning and characterization of the canine parietal cell gastrin receptor.

  1992cited by this paper
• The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.

  1991cited by this paper
• Use of photoaffinity probes containing poly(ethylene glycol) spacers for topographical mapping of the cholecystokinin receptor complex.

  1991cited by this paper
• An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium.

  1990cited by this paper
• The role of carbohydrate moieties of cholecystokinin receptors in cholecystokinin octapeptide binding: alteration of binding data by specific lectins.

  1990cited by this paper
• Gallbladder CCK receptors: species differences in glycosylation of similar protein cores.

  1990cited by this paper
• Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion.

  1989cited by this paper
• The lipid environment of the nicotinic acetylcholine receptor in native and reconstituted membranes.

  1989cited by this paper
• Purification and characterization of the rat pancreatic cholecystokinin receptor.

  1989cited by this paper
• Protease peptide mapping of affinity-labeled rat pancreatic cholecystokinin-binding proteins.

  1989cited by this paper
• Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptor.

  1989cited by this paper
• Regulation by high density lipoproteins of muscarinic acetylcholine receptor function in chick heart cells cultured in defined medium.

  1989cited by this paper
• Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28,31,pNO2-Phe33)CCK-26-33).

  1988cited by this paper
• Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor.

  1987cited by this paper
• Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor.

  1987cited by this paper
• A new generation of Ca2+ indicators with greatly improved fluorescence properties.

  1985cited by this paper
• Pancreatic CCK receptors: characterization of covalently labeled subunits.

  1984cited by this paper
• Identification and localization of cholecystokinin-binding sites on rat pancreatic plasma membranes and acinar cells: a biochemical and autoradiographic study

  1983cited by this paper
• Specific photoaffinity crosslinking of [125I]cholecystokinin to pancreatic plasma membranes. Evidence for a disulfide-linked Mr 76 000 peptide in cholecystokinin receptors.

  1982cited by this paper
• Preparation and characterization of a probe for the cholecystokinin octapeptide receptor, N alpha (125I-desaminotyrosyl)CCK-8, and its interactions with pancreatic acini.

  1981cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• COMPOSITION OF CELLULAR MEMBRANES IN THE PANCREAS OF THE GUINEA PIG

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Impact of secretin receptor homo-dimerization on natural ligand binding

  2024cites this paper
• Mechanism of Action and Structure–Activity Relationships of Tetracyclic Small Molecules Acting as Universal Positive Allosteric Modulators of the Cholecystokinin Receptor

  2023cites this paper
• Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor

  2022cites this paper
• Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol

  2021cites this paper
• Rational development of a high-affinity secretin receptor antagonist.

  2020cites this paper
• Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor

  2019cites this paper
• 1 Spatial Intensity Distribution Analysis Quantifies the Extent and Regulation of Homo-Dimerization of the Secretin Receptor

  2017cites this paper
• Spatial intensity distribution analysis quantifies the extent and regulation of homodimerization of the secretin receptor

  2017cites this paper
• Coexpressed Class B G Protein–Coupled Secretin and GLP-1 Receptors Self- and Cross-Associate: Impact on Pancreatic Islets

  2017cites this paper
• proteins with the class B secretin receptor Differential determinants for coupling of distinct G

  2016cites this paper
• Secretin Receptor

  2016cites this paper
• Structure and Function of Cross-class Complexes of G Protein-coupled Secretin and Angiotensin 1a Receptors*

  2016cites this paper
• Development of a Highly Selective Allosteric Antagonist Radioligand for the Type 1 Cholecystokinin Receptor and Elucidation of Its Molecular Basis of Binding

  2015cites this paper
• Use of Fluorescence Indicators in Receptor Ligands.

  2015cites this paper
• Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.

  2015cites this paper
• A Type 1 Cholecystokinin Receptor Mutant That Mimics the Dysfunction Observed for Wild Type Receptor in a High Cholesterol Environment*

  2014cites this paper
• Environment Wild Type Receptor in a High Cholesterol That Mimics the Dysfunction Observed for A Type 1 Cholecystokinin Receptor Mutant

  2014cites this paper
• A type 1 CCK receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment*

  2014cites this paper
• Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling.

  2013cites this paper
• Molecular Basis for Benzodiazepine Agonist Action at the Type 1 Cholecystokinin Receptor*

  2013cites this paper
• CCK, PYY and PP: the control of energy balance.

  2012cites this paper
• Appetite Control

  2012cites this paper
• Differential determinants for coupling of distinct G proteins with the class B secretin receptor.

  2012cites this paper
• Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor*

  2012cites this paper
• Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity.

  2012cites this paper
• Photoaffinity labeling of pancreatic receptors

  2011cites this paper
• Fluorescence Polarization Screening for Allosteric Small Molecule Ligands of the Cholecystokinin Receptor

  2011cites this paper
• Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore*

  2011cites this paper
• Lactam constraints provide insights into the receptor-bound conformation of secretin and stabilize a receptor antagonist.

  2011cites this paper
• Refinement of Glucagon-like Peptide 1 Docking to Its Intact Receptor Using Mid-region Photolabile Probes and Molecular Modeling*

  2011cites this paper
• Secretin Occupies a Single Protomer of the Homodimeric Secretin Receptor Complex

  2010cites this paper
• Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.

  2010cites this paper
• Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor.

  2010cites this paper
• Elucidation of the active conformation of the amino terminus of receptor-bound secretin using intramolecular disulfide bond constraints.

  2010cites this paper
• Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor

  2010cites this paper
• Functional and Structural Diversification of the Anguimorpha Lizard Venom System*

  2010cites this paper
• Modulation of cell surface expression of nonactivated cholecystokinin receptors using bivalent ligand-induced internalization.

  2010cites this paper
• Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor

  2009cites this paper
• Juxtamembranous Region of the Amino Terminus of the Family B G Protein-coupled Calcitonin Receptor Plays a Critical Role in Small-molecule Agonist Action*

  2009cites this paper
• Induced association of mu opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands.

  2009cites this paper
• Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.

  2009cites this paper
• Effects of pH and temperature on photoaffinity labeling of Family B G protein-coupled receptors.

  2009cites this paper
• Molecular Basis of Glucagon-like Peptide 1 Docking to Its Intact Receptor Studied with Carboxyl-terminal Photolabile Probes*

  2009cites this paper
• Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.

  2009cites this paper
• Glycosaminoglycan chains from alpha5beta1 integrin are involved in fibronectin-dependent cell migration.

  2009cites this paper
• Glycosaminoglycan chains from a 5 b 1 integrin are involved in fibronectin-dependent cell migration 1

  2009cites this paper
• Use of fluorescence indicators in receptor ligands.

  2009cites this paper
• Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor.

  2008cites this paper
• Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors.

  2008cites this paper
• Structural basis of cholecystokinin receptor binding and regulation.

  2008cites this paper
• Spatial Approximation between Secretin Residue Five and the Third Extracellular Loop of Its Receptor Provides New Insight into the Molecular Basis of Natural Agonist Binding

  2008influential citation
• Effects of cholecystokinin-58 on type 1 cholecystokinin receptor function and regulation.

  2008cites this paper
• Role of lysine187 within the second extracellular loop of the type A cholecystokinin receptor in agonist-induced activation. Use of complementary charge-reversal mutagenesis to define a functionally important interdomain interaction.

  2007cites this paper
• Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor*

  2007cites this paper
• Molecular Approximations between Residues 21 and 23 of Secretin and Its Receptor: Development of a Model for Peptide Docking with the Amino Terminus of the Secretin Receptor

  2007cites this paper
• Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.

  2006cites this paper
• Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats.

  2006cites this paper
• Fluorescence Characteristics of Hydrophobic Partial Agonist Probes of the Cholecystokinin Receptor

  2006cites this paper
• Possible Endogenous Agonist Mechanism for the Activation of Secretin Family G Protein-Coupled Receptors

  2006cites this paper
• Fluorescent Indicators Distributed throughout the Pharmacophore of Cholecystokinin Provide Insights into Distinct Modes of Binding and Activation of Type A and B Cholecystokinin Receptors*

  2006cites this paper
• Differential spatial approximation between secretin and its receptor residues in active and inactive conformations demonstrated by photoaffinity labeling.

  2006cites this paper
• Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

  2006cites this paper
• Paired Cysteine Mutagenesis to Establish the Pattern of Disulfide Bonds in the Functional Intact Secretin Receptor*

  2005cites this paper
• Differential Spatial Approximation between Cholecystokinin Residue 30 and Receptor Residues in Active and Inactive Conformations

  2005influential citation
• Insights into the structure and molecular basis of ligand docking to the G protein-coupled secretin receptor using charge-modified amino-terminal agonist probes.

  2005cites this paper
• Differential Effects of Modification of Membrane Cholesterol and Sphingolipids on the Conformation, Function, and Trafficking of the G Protein-coupled Cholecystokinin Receptor*

  2005cites this paper
• Analysis of the cellular and molecular mechanisms of trophic action of a misspliced form of the type B cholecystokinin receptor present in colon and pancreatic cancer.

  2005cites this paper
• Demonstration of a Specific Site of Covalent Labeling of the Human Motilin Receptor Using a Biologically Active Photolabile Motilin Analog

  2005cites this paper
• Distinct Molecular Mechanisms for Agonist Peptide Binding to Types A and B Cholecystokinin Receptors Demonstrated Using Fluorescence Spectroscopy*

  2005cites this paper
• Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.

  2005cites this paper
• Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor*

  2004cites this paper
• Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.

  2004cites this paper
• Molecular Approximation between a Residue in the Amino-terminal Region of Calcitonin and the Third Extracellular Loop of the Class B G Protein-coupled Calcitonin Receptor*

  2004cites this paper
• Key Differences in Molecular Complexes of the Cholecystokinin Receptor with Structurally Related Peptide Agonist, Partial Agonist, and Antagonist

  2004cites this paper
• Suppression of neurite outgrowth by high-dose nerve growth factor is independent of functional p75NTR receptors.

  2004cites this paper
• Functional characterization and purification of the secretin receptor expressed in baculovirus-infected insect cells.

  2004cites this paper
• hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.

  2004cites this paper
• Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors

  2004cites this paper
• Differential bile-pancreatic secretory effects of CCK-58 and CCK-8.

  2004cites this paper
• Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor.

  2003cites this paper
• Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor: specific mono-reactive receptor constructs examine charge-sensitivity of loop regions.

  2003cites this paper
• Spatial Approximation between Two Residues in the Mid-region of Secretin and the Amino Terminus of Its Receptor

  2003cites this paper
• Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10.

  2002cites this paper
• Differential Determinants for Peptide and Non-peptidyl Ligand Binding to the Motilin Receptor

  2002cites this paper
• Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.

  2002cites this paper
• Environment and Mobility of a Series of Fluorescent Reporters at the Amino Terminus of Structurally Related Peptide Agonists and Antagonists Bound to the Cholecystokinin Receptor*

  2002cites this paper
• Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.

  2002cites this paper
• Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy Transfer*

  2001cites this paper
• Refinement of the Structure of the Ligand-occupied Cholecystokinin Receptor Using a Photolabile Amino-terminal Probe*

  2001cites this paper
• Identification of Peptide Ligand-binding Domains within the Human Motilin Receptor Using Photoaffinity Labeling*

  2001cites this paper
• Molecular characterization and organ distribution of type A and B cholecystokinin receptors in cynomolgus monkey.

  2001cites this paper
• CCK receptor phosphorylation exposes regulatory domains affecting phosphorylation and receptor trafficking.

  2000cites this paper
• Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues.

  2000cites this paper
• Identification of Two Pairs of Spatially Approximated Residues within the Carboxyl Terminus of Secretin and Its Receptor*

  2000cites this paper
• Impaired resensitization and recycling of the cholecystokinin receptor by co-expression of its second intracellular loop.

  2000cites this paper
• Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling*

  1999cites this paper
• A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.

  1999cites this paper
• Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist.

  1999cites this paper
• Identification of an Interaction between Residue 6 of the Natural Peptide Ligand and a Distinct Residue within the Amino-terminal Tail of the Secretin Receptor*

  1999cites this paper
• Structurally Related Peptide Agonist, Partial Agonist, and Antagonist Occupy a Similar Binding Pocket within the Cholecystokinin Receptor

  1999cites this paper